Skip to main content
letter
. 2012 Mar 20;106(9):1560–1563. doi: 10.1038/bjc.2012.96

Table 2. Hazard ratios (HRs) for death and recurrence with 95% confidence intervals (CIs) according to partner's vital status among 21 213 women with breast cancer diagnosed in 1994–2006, Denmark.

        Crude a
Adjusted HR b
Adjusted HR c
  N Person years Events HR (95% CI) HR (95% CI) HR (95% CI)
All-cause mortality
 Partner alive at exit (ref.) 18 192 144 410 4977 1.00   1.00   1.00  
 Exposed in the 4 years before diagnosis 762 5216 243 1.14 (1.00, 1.30) 1.07 (0.94, 1.22) 1.10 (0.95, 1.27)
 Exposed 0–17 years after diagnosis 2259 23 147 440 1.12 (1.01, 1.25) 1.09 (0.98, 1.20) 1.09 (0.98, 1.22)
                   
Recurrence
 Partner alive at exit (ref.) 19 312 86 453 2635 1.00   1.00   1.00  
 Exposed in the 4 years before diagnosis 762 2839 59 0.83 (0.64, 1.08) 0.82 (0.63, 1.06) 0.82 (0.61, 1.09)
 Exposed 0–17 years after diagnosis 1139 7581 85 0.98 (0.78, 1.22) 0.97 (0.78, 1.21) 0.93 (0.73, 1.18)
a

Stratified by age at diagnosis in 1-year intervals.

b

Adjusted for the highest-attained educational level, disposable income, and stratified by age at diagnosis in 1-year intervals (defined in Table 1).

c

Adjusted for the highest-attained educational level, disposable income, period of diagnosis, comorbidity, tumour size, no. of tumour-positive lymph-nodes, hormone receptor status, malignancy grade and stratified by age at diagnosis in 1-year intervals (N=19 186) (defined in Table 1).